Aciex Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Westborough Massachusetts United States (2007)
Status: Acquired by NicOx (2014)

Organization Overview

First Clinical Trial
2010
NCT01134328
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

olopatadine (patanol) (7 trials)

Drugs in Phase 2 Trials (2)

cetirizine (zyrtec) (1 trial)

fluticasone (cutivate) (1 trial)

Drugs in Phase 1 Trials (1)

hypromelloses (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 3)

Conjunctivitis, Allergic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 4